TY  - GEN
AU  - Wang,Jinfen
AU  - Xu-Monette,Zijun Y
AU  - Jabbar,Kausar J
AU  - Shen,Qi
AU  - Manyam,Ganiraju C
AU  - Tzankov,Alexandar
AU  - Visco,Carlo
AU  - Wang,Jing
AU  - Montes-Moreno,Santiago
AU  - Dybkær,Karen
AU  - Tam,Wayne
AU  - Bhagat,Govind
AU  - Hsi,Eric D
AU  - van Krieken,J Han
AU  - Ponzoni,Maurilio
AU  - Ferreri,Andrés J M
AU  - Wang,Shi
AU  - Møller,Michael B
AU  - Piris,Miguel A
AU  - Medeiros,L Jeffrey
AU  - Li,Yong
AU  - Pham,Lan V
AU  - Young,Ken H
TI  - AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma
SN  - 1525-2191
PY  - 2017///0912
KW  - Apoptosis
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Heterocyclic Compounds, 3-Ring
KW  - pharmacology
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - MicroRNAs
KW  - metabolism
KW  - Middle Aged
KW  - Phosphorylation
KW  - Prognosis
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-akt
KW  - Signal Transduction
KW  - Survival Rate
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ajpath.2017.04.009
ER  -